Torrent Pharmaceuticals surged 5.59% to Rs 1,475.05 at 09:53 IST on BSE after consolidated net profit jumped 75.4% to Rs 449 crore on 73.2% growth in total income to Rs 2014 crore in Q1 June 2015 over Q1 June 2014.
The Q1 result was announced after market hours yesterday, 27 July 2015.
Meanwhile, the S&P BSE Sensex was down 30.31 points or 0.11% at 27,521.47
On BSE, so far 63,643 shares were traded in the counter as against average daily volume of 10,311 shares in the past one quarter.
The stock scaled a record high of Rs 1,520 in intraday trade today, 28 July 2015. The stock hit a low of Rs 1,462.50 so far during the day. The stock had hit a 52-week low of Rs 690 on 25 July 2014.
Also Read
The large-cap pharma firm has equity capital of Rs 84.61 crore. Face value per share is Rs 5.
Torrent Pharmaceuticals' EBITDA (earnings before interest, taxation, depreciation and amortization) rose 156% to Rs 974 crore in Q1 June 2015 over Q1 June 2014.
Torrent Pharmaceuticals attributed the exceptional growth in revenue and net profit in Q1 June 2015 to launch of a new product in US market, which currently has limited competition. The continuation of this is dependent on competitive market conditions, the company said in a statement.
Torrent Pharmaceuticals is a flagship company of Torrent Group. It is engaged in manufacturing of formulations and bulk drugs.
Powered by Capital Market - Live News
